Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in J Interferon Cytokine Res

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    March 2017
  1. NELSON M, Rubio R, Lazzarin A, Romanova S, et al
    Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
    J Interferon Cytokine Res. 2017;37:103-111.
    PubMed     Text format     Abstract available


    February 2017
  2. FOUAD R, Zachariah K, Khairy M, Khorshied M, et al
    Single Nucleotide rs760370 Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon-Riba
    J Interferon Cytokine Res. 2017;37:90-96.
    PubMed     Text format     Abstract available


    January 2017
  3. BESHEER T, El-Bendary M, Elalfy H, Abd El-Maksoud M, et al
    Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.
    J Interferon Cytokine Res. 2017 Jan 9. doi: 10.1089/jir.2016.0111.
    PubMed     Text format     Abstract available


    November 2016
  4. YI RT, Niu YH, Liu HL, Zhang TY, et al
    Natural Killer Group 2A Expressed on Both Peripheral CD3-CD56+NK Cells and CD3+CD8+T Cells Plays a Pivotal Negative Regulatory Role in the Progression of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  5. AFIFY M, Hamza AH, Alomari RA
    Correlation Between Serum Cytokines, Interferons, and Liver Functions in Hepatitis C Virus Patients.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  6. IBRAHIM MK, Salama H, Abd El Rahman M, Dawood RM, et al
    Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  7. ZWIRTES R, Narasimhan P, Wind-Rotolo MM, Xu D, et al
    Mechanisms of Hyperbilirubinemia During Peginterferon Lambda-1a Therapy for Chronic Hepatitis C Infection: A Retrospective Investigation.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  8. MOGAHED EA, Abdelaziz H, Helmy H, Ghita H, et al
    Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  9. VAN RIJNSOEVER M, Galhenage S, Mollison L, Gummer J, et al
    Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis C.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  10. HAMZA I, Eid Y, El-Sayed M, Marzaban R, et al
    Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  11. FLISIAK R, Kawazoe S, Znoyko O, Assy N, et al
    Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  12. MIUMA S, Ichikawa T, Miyaaki H, Haraguchi M, et al
    Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation.
    J Interferon Cytokine Res. 2016;36:358-66.
    PubMed     Text format     Abstract available


    March 2016
  13. ESMAT GE, Al Akel W, Abdel Aziz RA, Al Sayed Taha A, et al
    Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
    J Interferon Cytokine Res. 2016;36:149-58.
    PubMed     Text format     Abstract available


    February 2016
  14. EL RAZIKY M, Fathalah WF, Zakaria Z, Gamal Eldeen H, et al
    Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  15. LIU X, Shen Z, Zhang H, Liang J, et al
    Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    December 2015
  16. VEILLON P, Fouchard-Hubert I, Larrey D, Dao MT, et al
    Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  17. ZHANG T, Zhang Z, Zhang Y, Ye J, et al
    A Lower PBMC Estrogen Receptor alpha Gene Expression in Chronic Hepatitis B Is Associated with a Sustained Virological Response to Pegylated Interferon.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


    September 2015
  18. EL-KARAKSY HM, Mogahed EA, El-Raziky MS, Saleh D, et al
    Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


  19. FREDLUND P, Hillson J, Gray T, Shemanski L, et al
    Peginterferon Lambda-1a is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


    August 2015
  20. CHIEN CH, Lin CL, Hu CC, Chang JJ, et al
    Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


  21. NORITAKE H, Kobayashi Y, Ooba Y, Matsunaga E, et al
    Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  22. SEHGAL M, Zeremski M, Talal AH, Ginwala R, et al
    IFN-alpha-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


  23. YAN T, He Y, Li Y, Wang J, et al
    With Cytometric Bead Assay, the Interleukin-10/HBV DNA Ratio Is an Early Predictor for Response to Interferon-alpha Treatment in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


  24. ZHAO PW, Shi X, Li C, Ayana DA, et al
    IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.
    J Interferon Cytokine Res. 2015;35:454-63.
    PubMed     Text format     Abstract available


    May 2015
  25. RAZIKY ME, Elsharkawy A, Said SE, Abdelatty S, et al
    IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: